Tivic Health Systems Files 8-K
Ticker: TIVC · Form: 8-K · Filed: Dec 23, 2024 · CIK: 1787740
Sentiment: neutral
Topics: 8-k, disclosure, filing
TL;DR
Tivic Health filed an 8-K on 12/23/24 for Reg FD and exhibits. No major news yet.
AI Summary
Tivic Health Systems, Inc. filed an 8-K on December 23, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the reporting of these items.
Why It Matters
This 8-K filing indicates that Tivic Health Systems, Inc. is providing updates or disclosures to the SEC, which could include important regulatory or financial information for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, without immediate indication of significant negative events.
Key Players & Entities
- Tivic Health Systems, Inc. (company) — Registrant
- December 23, 2024 (date) — Date of Report
- 47685 Lakeview Blvd., Fremont, California 94538 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Tivic Health Systems, Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits, as of December 23, 2024.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is December 23, 2024.
What is the principal executive office address for Tivic Health Systems, Inc.?
The principal executive office address for Tivic Health Systems, Inc. is 47685 Lakeview Blvd., Fremont, California 94538.
What is the company's telephone number as listed in the filing?
The company's telephone number, including area code, is 888 276-6888.
What is the SIC code for Tivic Health Systems, Inc.?
The Standard Industrial Classification (SIC) code for Tivic Health Systems, Inc. is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Stats: 756 words · 3 min read · ~3 pages · Grade level 12.2 · Accepted 2024-12-23 16:47:43
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share TIVC The Nasdaq Stock Mar
Filing Documents
- tivic_8k.htm (8-K) — 28KB
- tivic_ex9901.htm (EX-99.1) — 22KB
- image_002.jpg (GRAPHIC) — 3KB
- 0001683168-24-008948.txt ( ) — 231KB
- tivc-20241223.xsd (EX-101.SCH) — 3KB
- tivc-20241223_lab.xml (EX-101.LAB) — 33KB
- tivc-20241223_pre.xml (EX-101.PRE) — 22KB
- tivic_8k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On December 23, 2024, Tivic Health Systems, Inc. (the "Company") issued a letter to its stockholders. A copy of this letter is furnished as Exhibit 99.1 to this Current Report, and is incorporated herein by reference. The information set forth under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
Forward-Looking Statements
Forward-Looking Statements This Current Report, including Exhibit 99.1 attached hereto, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms "anticipates," "expects," "estimates," "believes," "will" and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements.
Forward-looking statements in this Current Report,
Forward-looking statements in this Current Report, including Exhibit 99.1 attached hereto, or hereafter, including in other publicly available documents filed with the Securities and Exchange Commission, reports to the stockholders of the Company and other publicly available statements issued or released by us involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. Such future results are based upon management's best estimates based upon current conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Securities and Exchange Commission, each of which could adversely affect our business and the accuracy of the forward-looking statements contained herein
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Letter to Stockholders, dated December 23, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TIVIC HEALTH SYSTEMS, INC. Date: December 23, 2024 By: /s/ Jennifer Ernst Name: Jennifer Ernst Title: Chief Executive Officer 3